Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Finley, Melissa R ^a   Li, Yan ^a   Hua, Fei ^a   Lillich, James ^a   Mitchell, Kathy E ^a   Ganta, Suhasini ^a   Gilmour Jr , Robert F ^a   Freeman, Lisa C ^a,b  

^a KANSAS STATE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Equine cardiology; IsK; KCNH2; KvLQT1; minK; MiRP; Repolarization

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL PROTEIN; PROTEIN; PROTEIN ERG 1; PROTEIN KCNE 1; PROTEIN KCNQ 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HORSE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036299755     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00622.2001     Document Type: Article

References (59)

1. Kr potassium channels with HERG and is associated with cardiac arrhythmia
2. Ks cardiac potassium current
3. + channels?
4. + current in the ferret heart
5. Ks in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B
6. + channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias
7. Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE 2
8. + channel by dual pathways
9. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
10. Role of prokinetic drugs for treatment of postoperative ileus in the horse
11. Differential expression of KvLQT 1 and its regulator IsK in mouse epithelia
12. A dominant negative isoform of the long QT syndrome 1 gene product
13. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval
14. Cardiovascular adaptations to exercise and training
15. Cloning and expression of the delayed-rectifier IsK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus
16. + channel protein in mammalian cells and immunolocalization in guinea pig heart
17. Glycosylation influences gating and pH sensitivity of IsK
18. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications
19. Observations on the T wave of the equine electrocardiogram
20. Suppression of slow delayed rectifier current by a truncated isoform of KvLQT 1 cloned from normal human heart
21. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation
22. Human KvLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements
23. + channel in mouse and human hearts
24. Ventricular tachycardia associated with exhaustive exercise in a horse
25. Phosphorylation and thermostability of the KCNE1/KCNQ1 complex in heart and granulosa cells
26. + current
27. Species plays an important role in drug-induced prolongation of action potential duration and early after depolarizations in isolated Purkinje fibers
28. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]
29. Type-II renal tubular acidosis and ventricular tachycardia in a horse
30. Molecular basis of voltage-dependent potassium channels in porcine granulosa cells
31. Kr
32. Biophysical properties and molecular basis of cardiac rapid and slow delayed rectifier potassium channels
33. + channel by the gastrointestinal prokinetic agent cisapride
34. + currents by an antisense oligodeoxynucleotide against IsK (minK) and over-expression of IsK mutant D77N in neonatal mouse hearts
35. N-linked glycosylation sites determine HERG channel surface membrane expression
36. Kr channels
37. A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity blockade of the human cardiac potassium channel HERG
38. Treatment of atrial fibrillation in horses: New perspectives
39. + channel subunits
40. Ks potassium channel
41. + current. Differential sensitivity to block by class III antiarrhythmic agents
42. A constitutively open potassium channel formed by KCNQ 1 and KCNE3
43. Ks by (R)-2-(2,4-trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2, 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide
44. A common polymorphism associated with antibiotic-induced cardiac arrhythmia
45. Ks function
46. Chromanol 293B inhibits slowly activating delayed rectifier and transient outward currents in canine left ventricular myocytes
47. Alteration of channel activities and gating by mutations of slow IsK potassium channel
48. MinK subdomains that mediate modulation of and association with KvLQT 1
49. KCNE 2 confers background current characteristics to the cardiac KCNQ1 potassium channel
50. Kr: The hERG channel
51. Positional cloning of a novel potassium channel gene: KvLQT 1 mutations cause cardiac arrhythmias
52. Functional effects of mutations in KvLQT 1 that cause long QT syndrome
53. + channel, erg
54. + current
55. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias
56. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects
57. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature